Ergoteles LLC - VOR BIOPHARMA INC ownership

VOR BIOPHARMA INC's ticker is VOR and the CUSIP is 929033108. A total of 59 filers reported holding VOR BIOPHARMA INC in Q4 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.5%.

Quarter-by-quarter ownership
Ergoteles LLC ownership history of VOR BIOPHARMA INC
ValueSharesWeighting
Q4 2022$152,006
-41.5%
22,858
-65.0%
0.01%
-33.3%
Q3 2022$260,000
-39.5%
65,332
-24.4%
0.01%
-30.8%
Q2 2022$430,000
+343.3%
86,423
+440.1%
0.01%
+225.0%
Q1 2022$97,00016,0000.00%
Other shareholders
VOR BIOPHARMA INC shareholders Q4 2022
NameSharesValueWeighting ↓
5AM Venture Management, LLC 6,692,429$124,814,00031.41%
Trustees of Columbia University in the City of New York 183,821$3,428,0005.06%
RA Capital Management 11,120,973$207,406,0003.33%
Johnson & Johnson Innovation - JJDC, Inc. 1,074,658$20,042,0002.05%
Sarissa Capital Management LP 707,010$13,186,0001.05%
SECTORAL ASSET MANAGEMENT INC 405,324$7,559,0000.61%
Woodline Partners LP 1,146,494$21,382,0000.40%
Artal Group S.A. 550,000$10,258,0000.21%
NEXPOINT ASSET MANAGEMENT, L.P. 50,000$933,0000.20%
Orbimed Advisors 833,333$15,542,0000.16%
View complete list of VOR BIOPHARMA INC shareholders